Table I.
First author | Year | Ethnicity | Source of control | Genotyping | Sample size of case | Sample size of control | PHWE | Frequencyof f allele | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ff | fF | FF | Total | ff | fF | FF | Total | |||||||
Correa | 1999 | Caucasian | Population-based | PCR-RFLP | 10 | 58 | 50 | 118 | 9 | 42 | 38 | 89 | 0.598 | 0.337 |
Chokkalingam | 2001 | Asian | Hospital-based | PCR-RFLP | 41 | 95 | 51 | 187 | 62 | 153 | 87 | 302 | 0.725 | 0.459 |
Tayeb | 2004 | Caucasian | Population-based | PCR-RFLP | 2 | 10 | 16 | 28 | 11 | 24 | 21 | 56 | 0.391 | 0.411 |
Oakley-Girvan | 2004 | Caucasian | Population-based | PCR-RFLP | 27 | 120 | 85 | 232 | 26 | 77 | 68 | 171 | 0.586 | 0.377 |
Oakley-Girvan | 2004 | African-American | Population-based | PCR-RFLP | 4 | 25 | 84 | 113 | 5 | 42 | 74 | 121 | 0.752 | 0.215 |
Bodiwala | 2004 | Caucasian | BPH-based | PCR-RFLP | 60 | 163 | 145 | 368 | 35 | 100 | 108 | 243 | 0.137 | 0.350 |
Cheteri | 2004 | Caucasian | Population-based | PCR-RFLP | 101 | 247 | 204 | 552 | 80 | 234 | 207 | 521 | 0.305 | 0.378 |
Mishra | 2005 | Arabian | Hospital-based | PCR-RFLP | 5 | 45 | 78 | 128 | 16 | 69 | 62 | 147 | 0.622 | 0.344 |
John | 2005 | Caucasian | Population-based | PCR-RFLP | 69 | 203 | 153 | 425 | 57 | 209 | 171 | 437 | 0.581 | 0.370 |
Hayes | 2005 | Caucasian | Population-based | DGGE | 112 | 359 | 340 | 811 | 98 | 322 | 293 | 713 | 0.526 | 0.363 |
Cicek | 2006 | Mixed | Population-based | PCR-RFLP | 71 | 191 | 77 | 339 | 77 | 202 | 200 | 479 | 0.034 | 0.372 |
Huang | 2006 | Asian | Hospital-based | PCR-RFLP | 87 | 204 | 125 | 416 | 119 | 248 | 135 | 502 | 0.806 | 0.484 |
Rukin | 2007 | Caucasian | BPH-based | Pyrosequencing | 166 | 203 | 61 | 430 | 135 | 141 | 44 | 320 | 0.461 | 0.642 |
Mikhak | 2007 | Caucasian | Population-based | Taqman | 101 | 337 | 232 | 670 | 108 | 310 | 255 | 673 | 0.398 | 0.391 |
Li | 2007 | Caucasian | Population-based | PCR-RFLP | 152 | 475 | 383 | 1010 | 206 | 655 | 571 | 1432 | 0.413 | 0.373 |
Holick | 2007 | Caucasian | Population-based | SNPlex assay | 100 | 261 | 222 | 583 | 85 | 245 | 222 | 552 | 0.204 | 0.376 |
Torkko | 2008 | Spanish | Population-based | Taqman | 26 | 70 | 45 | 141 | 57 | 125 | 91 | 273 | 0.249 | 0.438 |
Torkko | 2008 | Caucasian | Population-based | Taqman | 67 | 209 | 168 | 444 | 63 | 227 | 198 | 488 | 0.87 | 0.362 |
Holt | 2009 | African-American | Population-based | SNPlex assay | 2 | 48 | 65 | 115 | 4 | 24 | 39 | 67 | 0.904 | 0.239 |
Holt | 2009 | Caucasian | Population-based | SNPlex assay | 108 | 335 | 262 | 705 | 101 | 352 | 263 | 716 | 0.332 | 0.387 |
Bai | 2009 | Asian | Hospital-based | PCR-RFLP | 26 | 63 | 33 | 122 | 37 | 55 | 38 | 130 | 0.08 | 0.496 |
Rowland | 2013 | African-American | Population-based | Taqman | 24 | 161 | 236 | 421 | 10 | 90 | 134 | 234 | 0.287 | 0.235 |
Rowland | 2013 | Caucasian | Population-based | Taqman | 193 | 598 | 406 | 1197 | 112 | 413 | 311 | 836 | 0.171 | 0.381 |
Yousaf | 2014 | Arabian | Hospital-based | PCR-RFLP | 2 | 0 | 39 | 41 | 13 | 0 | 95 | 108 | 0 | 0.120 |
Atoum | 2015 | Arabian | Population-based | PCR | 10 | 76 | 38 | 124 | 6 | 66 | 28 | 100 | 0 | 0.390 |
HWE – Hardy-Weinberg equilibrium of controls, RFLP – restriction fragment length polymorphism, BPH – benign prostatic hyperplasia.